NextCell Pharma AB's market cap is currently €9.76M. The company's EPS TTM is €-0.0089329; its P/E ratio is ―; NextCell Pharma AB is scheduled to report earnings on July 24, 2025, and the estimated EPS forecast is €>-0.01. See an overview of income statement, balance sheet, and cash flow financials.
